What drug‑drug and drug‑food interactions, as well as discharge counseling, should be advised for a patient taking cyclosporine and danazol?

Cyclosporine and Danazol: Critical Drug-Drug Interaction Requiring Dose Adjustment

Danazol significantly increases cyclosporine blood levels and renal toxicity risk, requiring close monitoring and cyclosporine dose reduction of 25-50% when used together. 1, 2

Drug-Drug Interaction Between Cyclosporine and Danazol

Mechanism and Clinical Significance

• Danazol is a documented CYP3A4 inhibitor that increases cyclosporine concentrations, leading to enhanced nephrotoxicity risk 1, 2, 3
• The FDA labels explicitly list danazol among drugs that increase cyclosporine concentrations through cytochrome P450 3A4 inhibition 1
• Danazol can raise plasma levels of cyclosporine, directly increasing renal toxicity of this immunosuppressant 2
• This interaction is well-documented in multiple patients and considered clinically significant 3, 4

Monitoring Requirements at Discharge

Implement intensive monitoring when this combination cannot be avoided:

• Measure serum creatinine every 2 weeks initially, then monthly once stable 1
• Check cyclosporine blood levels more frequently when danazol is initiated or dose-adjusted 1, 5
• Reduce cyclosporine dose by 25-50% if serum creatinine rises ≥25% above baseline 1
• Discontinue cyclosporine if creatinine increases ≥50% above baseline or fails to reverse after two dose modifications 1
• Monitor blood pressure every 2 weeks for first 3 months, as both drugs can affect blood pressure 1
• Check CBC, liver function tests, potassium, magnesium, and lipids every 2 weeks initially, then monthly 1

Food Interactions

Grapefruit - Absolute Contraindication

Advise complete avoidance of grapefruit and grapefruit juice while on cyclosporine 6, 1

• Grapefruit inhibits CYP3A4 in gut and liver, causing unpredictable and potentially dangerous increases in cyclosporine blood levels 6
• The effect is variable between individuals and long-lasting, making it unsafe even if consumed at different times than medication 6
• This is emphasized in British Association of Dermatologists guidelines as essential patient counseling 6

Other Dietary Considerations

• Maintain consistent timing of cyclosporine administration relative to meals to minimize pharmacokinetic variability 1
• Avoid combining cyclosporine oral solution with milk, as this combination is unpalatable 1
• Dilute cyclosporine oral solution preferably with orange or apple juice at room temperature 1

Additional Critical Discharge Counseling

Signs Requiring Urgent Medical Attention

Instruct patient to seek immediate care for: 6

• Fever or flu-like illness
• Nausea, vomiting, abdominal pain, or dark urine (suggesting hepatotoxicity or nephrotoxicity)
• Unexplained bruising or bleeding
• Mouth ulceration or severe fatigue
• Breathlessness or persistent cough

Infection Risk and Vaccination

• Avoid live-attenuated vaccines during cyclosporine treatment; other vaccinations may be less effective 6
• Wait at least 3 months after stopping cyclosporine before receiving live vaccines 6
• Seek prompt medical attention if exposed to chickenpox or shingles (if no prior immunity) 6

Drug Interaction Warnings

• Inform all healthcare providers (including dentists, emergency physicians) about cyclosporine use before receiving any new medications 6
• Avoid NSAIDs when possible, as they potentiate cyclosporine nephrotoxicity, especially with dehydration 1
• St. John's Wort causes marked reduction in cyclosporine levels and must be avoided 6, 1

Common Side Effects to Monitor

• Gingival hyperplasia (practice good oral hygiene) 6
• Hypertrichosis (excessive hair growth) 7
• Tremor and headache 7

Reproductive Counseling

• Female patients must inform physician immediately if pregnancy occurs while on cyclosporine 6
• Cyclosporine passes into breast milk; discuss risks with breastfeeding 6

Clinical Pitfalls to Avoid

• Do not assume therapeutic efficacy based on dose alone—cyclosporine has narrow therapeutic index with wide inter-individual variability requiring blood level monitoring 3, 5
• Do not overlook the additive nephrotoxic potential when cyclosporine is combined with danazol, NSAIDs, or other nephrotoxic agents 1
• Do not delay dose reduction if creatinine rises ≥25% above baseline, as sustained elevation can lead to irreversible nephropathy 1
• Recognize that the intensity of immunosuppression with cyclosporine monotherapy in dermatology is significantly less than transplant regimens, but vigilance for infections and malignancy remains important 6, 8